4.8 Meeting Abstract

Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Journal

JOURNAL OF HEPATOLOGY
Volume 68, Issue -, Pages S3-S3

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(18)30224-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available